Role of WNT7B-induced noncanonical pathway in advanced prostate cancer

Dali Zheng1, Keith F Decker, Tianhua Zhou

  • 1Center for Pharmacogenomics, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Insights

WNT7B is a key gene in advanced prostate cancer growth and bone metastasis. Targeting this androgen receptor-regulated pathway may offer new treatments for castration-resistant prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Advanced prostate cancer often becomes castration-resistant, continuing to grow despite androgen deprivation therapy.
  • Androgen receptor (AR) signaling remains crucial for advanced prostate cancer growth, even without androgens.
  • Downstream AR target genes driving castration resistance are not well understood.

Purpose of the Study:

  • To identify novel androgen receptor (AR) target genes involved in castration-resistant prostate cancer (CRPC) progression.
  • To investigate the role of WNT7B in CRPC growth and osteoblastic bone metastasis.

Main Methods:

  • Gene expression analysis in CRPC cells.
  • Functional assays to assess WNT7B's role in cell growth under androgen-deprived conditions.
  • In vitro studies on WNT7B-induced osteoblast differentiation.
  • Analysis of WNT7B expression in prostate cancer xenografts.

Main Results:

  • WNT7B was identified as a direct AR target gene highly expressed in CRPC cells.
  • WNT7B expression is essential for prostate cancer cell growth, particularly under androgen deprivation.
  • WNT7B promotes androgen-independent CRPC growth, potentially via protein kinase C activation.
  • Prostate cancer-derived WNT7B induces osteoblast differentiation in vitro and is upregulated in bone metastatic xenografts.

Conclusions:

  • AR-regulated WNT7B signaling is critical for CRPC growth.
  • WNT7B plays a significant role in the development of osteoblastic bone responses in advanced prostate cancer.
  • Targeting WNT7B may represent a therapeutic strategy for advanced prostate cancer with bone metastasis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...